vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and EPLUS INC (PLUS). Click either name above to swap in a different company.

EPLUS INC is the larger business by last-quarter revenue ($614.8M vs $493.8M, roughly 1.2× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 5.7%, a 1.1% gap on every dollar of revenue. On growth, EPLUS INC posted the faster year-over-year revenue change (20.3% vs -1.7%). Over the past eight quarters, EPLUS INC's revenue compounded faster (2.3% CAGR vs -0.1%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

ePlus Inc.(Nasdaq: PLUS) is an American consultative technology solutions provider that provides solutions and advisory and managed services across the technology spectrum, including security, cloud, networking, collaboration, artificial intelligence, and emerging solutions to more than 5,000 customers.

MD vs PLUS — Head-to-Head

Bigger by revenue
PLUS
PLUS
1.2× larger
PLUS
$614.8M
$493.8M
MD
Growing faster (revenue YoY)
PLUS
PLUS
+22.0% gap
PLUS
20.3%
-1.7%
MD
Higher net margin
MD
MD
1.1% more per $
MD
6.8%
5.7%
PLUS
Faster 2-yr revenue CAGR
PLUS
PLUS
Annualised
PLUS
2.3%
-0.1%
MD

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
MD
MD
PLUS
PLUS
Revenue
$493.8M
$614.8M
Net Profit
$33.7M
$35.1M
Gross Margin
25.8%
Operating Margin
9.9%
7.1%
Net Margin
6.8%
5.7%
Revenue YoY
-1.7%
20.3%
Net Profit YoY
10.5%
45.2%
EPS (diluted)
$0.40
$1.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
PLUS
PLUS
Q4 25
$493.8M
$614.8M
Q3 25
$492.9M
$608.8M
Q2 25
$468.8M
$637.3M
Q1 25
$458.4M
Q4 24
$502.4M
$493.2M
Q3 24
$511.2M
$493.4M
Q2 24
$504.3M
$535.7M
Q1 24
$495.1M
Net Profit
MD
MD
PLUS
PLUS
Q4 25
$33.7M
$35.1M
Q3 25
$71.7M
$34.9M
Q2 25
$39.3M
$37.7M
Q1 25
$20.7M
Q4 24
$30.5M
$24.1M
Q3 24
$19.4M
$31.3M
Q2 24
$-153.0M
$27.3M
Q1 24
$4.0M
Gross Margin
MD
MD
PLUS
PLUS
Q4 25
25.8%
Q3 25
26.6%
Q2 25
23.3%
Q1 25
Q4 24
25.4%
Q3 24
25.8%
Q2 24
23.7%
Q1 24
Operating Margin
MD
MD
PLUS
PLUS
Q4 25
9.9%
7.1%
Q3 25
13.8%
8.0%
Q2 25
12.8%
5.7%
Q1 25
7.0%
Q4 24
7.8%
3.3%
Q3 24
6.6%
5.5%
Q2 24
-31.3%
5.9%
Q1 24
3.2%
Net Margin
MD
MD
PLUS
PLUS
Q4 25
6.8%
5.7%
Q3 25
14.5%
5.7%
Q2 25
8.4%
5.9%
Q1 25
4.5%
Q4 24
6.1%
4.9%
Q3 24
3.8%
6.3%
Q2 24
-30.3%
5.1%
Q1 24
0.8%
EPS (diluted)
MD
MD
PLUS
PLUS
Q4 25
$0.40
$1.33
Q3 25
$0.84
$1.32
Q2 25
$0.46
$1.43
Q1 25
$0.24
Q4 24
$0.37
$0.91
Q3 24
$0.23
$1.17
Q2 24
$-1.84
$1.02
Q1 24
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
PLUS
PLUS
Cash + ST InvestmentsLiquidity on hand
$375.2M
$326.3M
Total DebtLower is stronger
$570.5M
Stockholders' EquityBook value
$865.9M
$1.1B
Total Assets
$2.2B
$1.8B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
PLUS
PLUS
Q4 25
$375.2M
$326.3M
Q3 25
$340.1M
$402.2M
Q2 25
$224.7M
$480.2M
Q1 25
$99.0M
Q4 24
$229.9M
$253.1M
Q3 24
$103.8M
$187.5M
Q2 24
$19.4M
$349.9M
Q1 24
$8.0M
Total Debt
MD
MD
PLUS
PLUS
Q4 25
$570.5M
Q3 25
$577.2M
Q2 25
$583.9M
Q1 25
$590.5M
Q4 24
$597.1M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MD
MD
PLUS
PLUS
Q4 25
$865.9M
$1.1B
Q3 25
$890.7M
$1.0B
Q2 25
$833.8M
$1.0B
Q1 25
$789.2M
Q4 24
$764.9M
$962.3M
Q3 24
$732.5M
$947.0M
Q2 24
$706.5M
$921.9M
Q1 24
$856.2M
Total Assets
MD
MD
PLUS
PLUS
Q4 25
$2.2B
$1.8B
Q3 25
$2.2B
$1.8B
Q2 25
$2.1B
$1.8B
Q1 25
$2.0B
Q4 24
$2.2B
$1.8B
Q3 24
$2.1B
$1.7B
Q2 24
$2.0B
$1.7B
Q1 24
$2.2B
Debt / Equity
MD
MD
PLUS
PLUS
Q4 25
0.66×
Q3 25
0.65×
Q2 25
0.70×
Q1 25
0.75×
Q4 24
0.78×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
PLUS
PLUS
Operating Cash FlowLast quarter
$114.1M
$-87.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.39×
-2.49×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
PLUS
PLUS
Q4 25
$114.1M
$-87.4M
Q3 25
$137.3M
$-34.8M
Q2 25
$137.2M
$-99.0M
Q1 25
$-117.5M
Q4 24
$133.0M
$65.7M
Q3 24
$91.8M
$-21.6M
Q2 24
$107.0M
$97.1M
Q1 24
$-125.2M
Cash Conversion
MD
MD
PLUS
PLUS
Q4 25
3.39×
-2.49×
Q3 25
1.91×
-1.00×
Q2 25
3.49×
-2.63×
Q1 25
-5.66×
Q4 24
4.36×
2.72×
Q3 24
4.72×
-0.69×
Q2 24
3.55×
Q1 24
-31.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

PLUS
PLUS

All Others Customer End Market$107.0M17%
Technology Customer End Market$89.4M15%
Health Care Customer End Market$81.5M13%
Financial Services Customer End Market$66.1M11%
Professional Services Reporting Unit$64.1M10%
Security$61.1M10%
State And Local Government And Educational Institutions$59.9M10%
Managed Services Reporting Unit$48.8M8%
Other Product$21.1M3%
Collaboration$13.4M2%

Related Comparisons